Industry Focus

A flurry of news has investors clamoring to add Nektar Therapeutics to their portfolios. Plus, we explain why investors are disappointed by Loxo Oncology’s good news and how a new smart pill could change medicine forever.

Direct download: 20171115_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EST

1